|Previous Section||Index||Home Page|
Mrs. Lait: To ask the Secretary of State for Health how much money there was in the Mental Health Research and Development budget in each region (a) at the end of the financial year 1999-2000 and (b) at the beginning of financial year 2000-01. 
The Medical Research Council (MRC) is the main agency through which the Government supports research on the causes and treatment of disease. The MRC receives most of its income via grant-in-aid from the office of my right hon. Friend the Secretary of State for Trade and Industry. The Department funds research to support policy
3 May 2000 : Column: 174W
development in health and social care, and to support effective practice in the National Health Service. The Department also provides NHS support funding for research commissioned by the MRC and charities that takes place in the NHS.
The Department invests approximately £40 million per year on research directly relevant to mental health, £7 million on directly commissioned projects, and £33 million to support work on mental health funded by research councils and charities which is undertaken in the NHS. Management of the research supported by NHS research and development funding in trusts is devolved and details of expenditure at the project level are not currently collected routinely by the Department. It is not therefore possible to give accurate details of expenditure year by year.
Project details of work directly funded by the Department or supported through NHS research and development funding can be found on the National Research Register (NRR). This is available in the Library and most medical libraries on CD Rom, and on the Internet: http://www.doh.gov.uk/nrr.htm. The NRR also contains many details of projects/trials funded by the MRC and other funders.
Yvette Cooper: The table shows the number of finished consultant episodes where a heart operation was performed, and the number of finished consultant episodes where a coronary artery bypass graft was performed, in National Health Service hospitals in England for the years 1989-90 to 1998-99.
3 May 2000 : Column: 173W
|OPCS4R codes used/Procedure||1989-90||1990-91||1991-92||1992-93||1993-94||1994-95||1995-96||1996-97||1997-98||1998-99|
|K01-70/All heart ops||(23)--||83,065||106,374||120,394||130,502||148,797||153,736||162,146||161,890||177,650|
(23) Data for 1989-90 for all heart operations is currently unavailable.
1. Data in this table is grossed for both coverage and unknown/invalid clinical data, except for 1997-98 and 1998-99 which are ungrossed.
2. An FCE is defined as a period of patient care under one consultant in one health care provider. The figures do not represent the number of patients, as one person may have several episodes within the year.
3. These figures represent a count of all FCEs where the procedure was mentioned in any of the four operation fields in the HES data set
Hospital Episode Statistics (HES), Department of Health.
3 May 2000 : Column: 173W
Mr. Coleman: To ask the Secretary of State for Health what amounts each London borough claimed in excess of the maximum grant available from his Department for (a) single asylum seekers and (b) asylum families with children for (i) 1997-98 and (ii) 1998-99; and if he will make a statement. 
3 May 2000 : Column: 174W
3 May 2000 : Column: 175W
payable, any excess expenditure incurred above that sum would have to be met locally and not by central government.
|Adults||£140 per week|
|Families||80 per cent. of relevant expenditure above relevant local authority threshold|
|Adults||£165 per week|
|Families||£230 per family per week, or £240 in the case of any family of asylum seekers provided with services in Inner London prior to 23 November 1998|
Yvette Cooper: Squalene is not itself a vaccine, but has been licensed in Italy as an adjuvant to influenza vaccine. Monitoring of all vaccines given in the United Kingdom is performed by the Medicines Control Agency and the Committee on Safety of Medicines.
As for any new medicinal product, evaluation of research on the use of squalene as an adjuvant in vaccines, presented as part of a marketing application, would be performed by the Medicines Control Agency under conditions of commercial confidentiality.
Ms Stuart: No it will not replace the United Kingdom Food Standards Agency. The White Paper clearly states that the proposed European Food Authority must be a "value-added structure" which will work in close co-operation with national agencies and institutions, thus making the best use of existing structures and resources.
3 May 2000 : Column: 176W
Ms Stuart: The gross budget for the Food Standards Agency in its first full year (2000-01) is £148 million including £8 million for the executives in the devolved administrations, and £70 million for its executive agency, the Meat Hygiene Service. (The £148 million is net of internal transfers between the Food Standards Agency headquarters and the Meat Hygiene Service).
The Commission has proposed that the European Food Authority has a budget of only 100 million ecus (£62.5 million). We will have to be clear about whether this is an additional cost or total funding. Clearly most of the functions of the EFA are already performed elsewhere within the EU framework and we must be careful to avoid duplication of effort.
Ms Stuart: The Government believe that consumer concerns and the complexity of current arrangements demand urgent action to develop a coherent European Union policy for the foodstuffs sector based firmly on the fundamental importance of consumer protection. We welcome the White Paper and share the objective it outlines.
Ms Stuart: The proposed legislative programme contains many individual initiatives which the Government have been pressing for and some have been expected for some time. In a number of cases the legislation proposed is amending existing legislation. We await individual, more detailed, proposals to be brought forward by the European Commission.
Mr. Redwood: To ask the Secretary of State for Health what estimate he has made of the additional costs to (a) the British food industry and (b) farmers of the proposals set out in the EU's White Paper on food safety. 
Ms Stuart: None. The Commission has consulted widely on the White Paper and the Food Standards Agency has discussed various issues with key organisations, including those representing farmers and the food industry. They have been encouraged to respond direct to the Commission.
3 May 2000 : Column: 177W
Once individual proposals have been produced all interested stakeholders will be consulted. The United Kingdom will be pressing for proportionality, bearing in mind the need to safeguard the interests of the consumer.
|Next Section||Index||Home Page|